MedPath

Research on the Effect and Mechanism of Aerobic Exercise on PD

Not Applicable
Conditions
Parkinson's Disease
Physical Exercise
Interventions
Behavioral: aerobic exercise
Registration Number
NCT04651140
Lead Sponsor
The First Hospital of Jilin University
Brief Summary

This trial is expected to recruit patients with primary Parkinson's disease and give them four consecutive weeks of aerobic exercise to observe its effect on Parkinson's disease and explore its mechanism

Detailed Description

This trial is expected to recruit patients with primary Parkinson's disease who are distributed into tremor group and stiff group and give them the same kind of four consecutive weeks of aerobic exercise to observe its effect on Parkinson's disease and explore its mechanism

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Participants were diagnosed primary PD according to the 2015 MDS diagnostic criteria
  • Participants are between 55 and 65 years old
Exclusion Criteria
  • Severe heart
  • liver dysfunction
  • kidney dysfunction
  • severe cognitive dysfunction
  • severe anxiety and depression
  • history of mental illness
  • history of cerebral infarction or ischemic attack in the past three months
  • acute myocardial infarction or acute coronary in the past three months
  • Parkinson's Pulse syndrome
  • medication history (drugs that improve blood circulation in the brain and increase the excitability of the nervous system)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tremor groupaerobic exerciseParticipants in the tremor group have tremor as the main clinical manifestation
Stiff groupaerobic exerciseParticipants in the tremor group have stiff as the main clinical manifestation
Primary Outcome Measures
NameTimeMethod
Montreal Cognitive Assessing(MoCA) scorechanges of MoCA score from baseline at four weeks

to assess the cognitive function of PD,0-30 scores,the higher scores mean better function

Non-Motor Symptom Scale (NMSS)changes of NMSS score from baseline at four weeks

to assess the non-motor of PD , 0-120 scores, the higher scores mean severe non-motor damage

The Epworth Sleeping Scale(ESS)changes of ESS score from baseline at four weeks

to assess the degree of drowsiness, 0-24 scores, the higher scores mean severe drowsiness

Movement Disorder Society-United Parkinson's Disease Rating Scale (MDS-UPDRS)changes of MDS-UPDRS score from baseline at four weeks

to assess the motor and nonmotor function of PD,0-200 scores,the higher scores mean lower function

Secondary Outcome Measures
NameTimeMethod
the level of arterial blood pressurechanges of the arterial blood pressure from baseline at four weeks

arterial blood pressure is recorded using transcranial Doppler and a servo-controlled plethysmograph respectively. Both systolic and diastolic pressures will be assessed during the study period.

the concentration of microRNA in peripheral blood by gene chipchanges of microRNA from baseline at four weeks

to test the the concentration of microRNA in peripheral blood

cerebral blood variation by Head MRIchanges of the cerebral blood from baseline at four weeks

to assess the cerebral blood variation by head MRI

cerebral blood flow velocitychanges of the cerebral blood flow velocity from baseline at four weeks

cerebral blood flow velocity is recorded using transcranial Doppler and a servo-controlled plethysmograph respectively.

Trial Locations

Locations (1)

FirstJilinU

🇨🇳

Changchun, China

© Copyright 2025. All Rights Reserved by MedPath